These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 15757197

  • 21. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies.
    Zwirner P, Wilichowski E.
    Laryngoscope; 2001 Mar; 111(3):515-21. PubMed ID: 11224785
    [Abstract] [Full Text] [Related]

  • 22. Molecular and clinical characterization of the variable phenotype in Korean families with hearing loss associated with the mitochondrial A1555G mutation.
    Bae JW, Kim DB, Choi JY, Park HJ, Lee JD, Hur DG, Bae SH, Jung DJ, Lee SH, Kim UK, Lee KY.
    PLoS One; 2012 Mar; 7(8):e42463. PubMed ID: 22879993
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prevalence and clinical features of the mitochondrial m.1555A>G mutation in Taiwanese patients with idiopathic sensorineural hearing loss and association of haplogroup F with low penetrance in three families.
    Wu CC, Chiu YH, Chen PJ, Hsu CJ.
    Ear Hear; 2007 Jun; 28(3):332-42. PubMed ID: 17485982
    [Abstract] [Full Text] [Related]

  • 27. [Prevalence of the A1555G mutation in the mitochondrial DNA in patients with cochlear or vestibular damage due to aminoglycoside-induced ototoxicity].
    Gallo-Terán J, Arellano B, Morales-Angulo C, Modamio-Høybjør S, Moreno-Pelayo MA, Ramírez-Camacho R, del Castillo I, Moreno F.
    Acta Otorrinolaringol Esp; 2004 May; 55(5):212-7. PubMed ID: 15461317
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Assessment of the risk of hearing loss in children with cystic fibrosis].
    Polyakov DP, Daikhes NA, Bazanova MV, Melyanovskaya YL.
    Vestn Otorinolaringol; 2024 May; 89(3):29-35. PubMed ID: 39104270
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The clinical and audiologic features of hearing loss due to mitochondrial mutations.
    Yelverton JC, Arnos K, Xia XJ, Nance WE, Pandya A, Dodson KM.
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1017-22. PubMed ID: 23525847
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cochlear origin of hearing loss in MELAS syndrome.
    Sue CM, Lipsett LJ, Crimmins DS, Tsang CS, Boyages SC, Presgrave CM, Gibson WP, Byrne E, Morris JG.
    Ann Neurol; 1998 Mar; 43(3):350-9. PubMed ID: 9506552
    [Abstract] [Full Text] [Related]

  • 40. Genetic features, clinical phenotypes, and prevalence of sensorineural hearing loss associated with the 961delT mitochondrial mutation.
    Kobayashi K, Oguchi T, Asamura K, Miyagawa M, Horai S, Abe S, Usami S.
    Auris Nasus Larynx; 2005 Jun; 32(2):119-24. PubMed ID: 15917167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.